|
|
||||||||
Technical Developments |
1 From the Montreal Neurological Institute (K.M., C.J.T., J.L.R.), Medical Physics Unit (M.A., A.M.B., C.J.T.), and the Departments of Nuclear Medicine (R.L.), Surgical Oncology (A.L.), and Radiology (J.H.G.), the Royal Victoria Hospital, McGill University, 3801 University St, Rm 798, Montreal, Quebec H3A 2B4, Canada. Received September 29, 1998; revision requested December 23; final revision received August 4, 1999; accepted August 11. Supported in part by the National Cancer Institute of Canada, Canadian Breast Cancer Research Institute grant 6139. Address reprint requests to K.M. (e-mail: kavita@bic.mni.mcgill.ca).
| Abstract |
|---|
|
|
|---|
Index terms: Breast radiography, technology, 00.1219
| Introduction |
|---|
|
|
|---|
Early detection of cancer requires use of an instrument with very high spatial resolution and efficiency. The positron emission mammographic (PEM) instrument described herein was built in our laboratory on the basis of the basic principles of PET applied to the specific problem of breast cancer detection, and it produces high-spatial-resolution emission images of the breast with use of very low doses of FDG (811). In this study, we measured the spatial, timing, and contrast resolution characteristics of images obtained with the PEM instrument in the laboratory. Typical clinical scanning results are also presented.
In the case of PET and single photon emission computed tomography (SPECT) after image reconstructions and all corrections are applied, the image contrast equals the object contrast, provided the object size is more than twice the full width at half maximum (FWHM). These corrections cannot be applied to limited-angle back-projection images such as those obtained with our PEM instrument system. Therefore, scatter contribution cannot be eliminated from the reconstructed image. In previous work (12), we have shown that lesion detection ability is not compromised by performing limited-angle projection. However, the contrast detected will be lower than the true value, which can be obtained when the image is reconstructed from projections (13). In general, for object thickness (compressed breast) T and a tumor diameter D, true contrast (C, defined as the ratio of activity at the tumor to that at the background) at CT, the detector contrast CD is given with the following expression:
Ideally, if a point source is placed at the center of a cube of which two opposing faces can be considered detectors, then the probability that both annihilation photons would be directed toward the detectors is one-third or 33%. The probability (P) that an incident 511-keV photon will be attenuated (att) in a bismuth germanate (BGO) detector of thickness x and attenuation coefficient µBGO is given with
| Materials and Methods |
|---|
|
|
|---|
|
Data acquisition system.The energy thresholding utility of the PEM instrument software is used to window the processed events, apply spatial and energy distortion corrections, and perform limited-angle back projection to produce the final image. Coincidences between any two crystals are accepted, which gives 2,452 possible lines of response with the central plane sampled at a rate of two samples per millimeter. The space occupied by the compressed breast between the detectors is divided into seven imaging planes, and the intersection points of the lines of response with the planes are determined. Seven images are formed by adding a number N to the appropriate locations in a 128 x 128 imaging matrix (10). This number N is inversely proportional to the probability of the annihilation occurring in that plane. This technique is extremely fast, and it allows almost real-time display of the activity distribution (images are updated every 5 seconds). Additionally, it provides important depth information since imaging of the plane closest to an actual site of high activity results in acquisition of the best-focused image of the site. Full details of the acquisition system are in reference 9.
Intrinsic spatial resolution of detector pair.The spatial resolution of the PEM instrument system was measured by optically coupling one block of prepared BGO crystal to each photo multiplier tube. Two germanium 68 point sources were placed 10 mm apart at the midpoint of the detectors, which were separated by 10 cm. Coincidence data were acquired with an energy window of approximately 300700 keV. The experiment was repeated at each stage of crystal preparation starting with the uncut BGO block and ending with a block that was cut, acid etched, and filled with white epoxy.
System spatial resolution.The system spatial resolution was measured by filling capillary tubes with 1-mm inner diameter with radioactive solution of 18F and imaging them with 10-, 8-, and 5-mm separations. The peak-to-valley ratio for each experiment was calculated by drawing profiles through the back-projected image and calculating the average ratio of the local maxima to the local minima.
To compare performance of the PEM instrument system with that of a conventional PET brain scanner (Scanditronix PC2048; GE Medical Systems, Milwaukee, Wis) (15,16) used at the Brain Imaging Centre of the Montreal Neurological Institute, we performed identical experiments with the two instruments. Five capillary tubes with 1-mm inner diameter were filled with 18F solution and placed 5 mm apart; they were imaged with the conventional scanner for 10 minutes with use of a wobbled scanning protocol. The PET images were reconstructed by means of filtered back projection and ramp filtering into a 128 x 128-pixel image. Identical experiments were performed with the PEM instrument with one-fourth the activity and scanning time of 2 minutes.
Contrast resolution.The contrast resolution of the PEM instrument system was measured by using a custom-made phantom and a spheric 16-mm-diameter FDG hot spot without exterior walls (17). The phantom consisted of a 150 x 150 x 100-mm (high) rectangular box with a fine needle for positioning the hot spot at different positions. The depth of background activity was 70 mm, and initial hot-spot activity was 1.6 MBq. Activity was added to the background to simulate different values of true contrast ratio (hot-spot activity divided by background activity). An energy window of 350650 keV was used. All activities were measured in a well counter (model 802-3W; Canberra Packard, Mississauga, Ontario, Canada). With the energy window used to measure blood samples during conventional PET scanning, the efficiency of the counter was 0.24 cps/Bq.
System efficiency.System efficiency was measured by placing a 3-mm-diameter, 33-kBq FDG planar source at the midpoint of the central plane between the two detectors and recording the number of counts detected in a 60-second period as a function of the detector separation with use of an energy window of 350650 keV. The source activity was measured in the calibrated well counter and corrected for detection efficiency of the counter. The fraction of emitted annihilation photons detected by the PEM instrument detectors was plotted as a function of the detector separation.
System timing resolution.Timing resolution of the PEM instrument system was measured by means of the fast-slow coincidence technique. A time-to-amplitude converter (model 1443A; Canberra Packard) was used to convert the difference between the arrival times of the timing signals from opposing detectors into a single signal. The amplitude of this signal was proportional to the difference between the arrival times. The time axis was calibrated by inserting a known delay into the stop channel of the time-to-amplitude converter. The output was viewed on a multichannel analyzer.
Patient Scanning
Fifteen female patients (age range, 3475 years; mean age, 54.8 years) underwent scanning at the Cedars Breast Clinic at the Royal Victoria Hospital in Montreal. This study was approved by the institutional research ethics committee, and participants gave written informed consent. All patients were asked to urinate before the start of scanning to reduce the amount of scattered background radiation that entered the detectors and to minimize absorbed dose in the patient.
One of the patients (age, 75 years) had an abnormal x-ray mammogram that indicated the presence of an undiagnosed suspect dense mass in the right breast. A 75-MBq bolus of FDG was injected, and emission scanning was performed 40 minutes after injection. The patient's breast was positioned in the mammographic system with use of minimal compression. An x-ray mammographic image of the breast was obtained and subsequently digitized. The detectors in the PEM instrument system were positioned over the tumor site, and emission data were collected for 5 minutes. The PEM instrument produced a nearly real-time image of the breast as scanning progressed, with images that were updated every 5 seconds. The best focused of the seven PEM instrument images was scaled to match the size of the digitized x-ray mammographic image, and the two images were coregistered to result in a composite PEM instrument and x-ray mammographic image.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
Patient Scanning
Figure 7 shows typical clinical images obtained with the PEM instrument. In this patient, the abnormality was located almost centrally, slightly above the midplane. The seven emission images in the upper row represent seven horizontal sections through the left breast obtained after 300 seconds of data acquisition. The section closest to the tumor site (section 4 [from left to right]) is the best-focused image of the tumor, which allows an estimate of the depth of the tumor within the breast (1522 mm from the top of the breast). Figure 8 shows the coregistered composite PEM instrument and digitized x-ray mammographic image with the coregistration tool outlined in green. The location of increased glucose uptake corresponded to the location of the tumor. There was a fourfold increase in the relative number of counts detected at the tumor site compared with that in the rest of the breast. From the emission images, the size of the hot spot was estimated as 10 x 15 mm (horizontal x vertical dimensions). This was consistent with the clinical findings. Disease in this patient was subsequently diagnosed as intraductal and infiltrating ductal carcinoma with histologic grade of 3/3, measurements of 15 x 15 x 13 mm, and location in the laterosuperior aspect of the breast.
|
|
| Discussion |
|---|
|
|
|---|
Results in the contrast-resolution experiments show the close agreement of the detector contrast expected theoretically and the actual image contrast, which demonstrates that the scatter contribution to the image is minimal and can be effectively eliminated by means of appropriate choice of the low-energy threshold. With our PEM instrument system, a hot spot with a true contrast ratio of 6:1 compared with background was well resolved spatially.
The system efficiency (the fraction of total annihilation events detected with the PEM instrument detectors expressed as a percentage) varied from 4.7% (40-mm detector separation) to 0.7% (140-mm separation). The experimental value of the efficiency at 55-mm detector separation (3%) was a factor of more than five times lower than the theoretic prediction of 16% for a perfect system. Several factors contribute to the loss in efficiency. There was a loss of efficiency owing to the finite width of the coincidence timing window. Approximately 75% of events fell within the coincidence window of 12 nsec. The remaining events were rejected. This led to a further reduction in efficiency from 16% to 12%.
The single greatest source of loss of efficiency is dead time. Dead time for the PEM instrument had four distinct components: (a) the dead time associated with the decay time of the scintillation light (300 nsec for BGO) and that associated with the timing electronics for each detector unit; (b) the dead time associated with the coincidence detection system; (c) the finite time associated with the data interrogation between the analog-to-digital converter (model 14; Jorway Aurora, Westbury, NY) and computer (prior to the transfer of data between the converter and the computer), which is of the order of 0.30.4 µsec; and, most important, (d) the time associated with data readout. The converter in the present system cannot send an interrupt command when the memory buffers are nearly full. Instead, the computer polls the converter buffer every 0.1 second and initiates a data transfer if at least 1,024 events are in the buffer. Four milliseconds are required to transfer data to the computer. Data acquisition is disabled completely during the period when the converter is busy transferring information from its buffer to the computer memory. For a given detector separation, use of a higher input event rate would require more frequent data transfers, which would lead to lower efficiency. This is a shortcoming of the present data acquisition system that can be easily overcome by using two separate converters and alternately polling each, which would eliminate the dead time due to data transfers.
Results of the clinical study compared well with the histopathologic findings. The tumor location on the PEM instrument image correlated well with its position on the x-ray mammographic image. Wahl et al (4) report a median increase in FDG uptake of 8:1 in cancer cells compared with that in normal cells. In clinical application of the PEM instrument system, we believe that sites with high glucose uptake will be easily detected.
In summary, we designed and tested an instrument for PEM that makes use of pixilated BGO detectors and position-sensitive photomultiplier tubes to achieve high spatial resolution. In human subjects, the intrinsic spatial resolution of PEM instrument images is up to a factor of two better than that of conventional PET scans. Clinical PEM instrument images with good spatial resolution can be obtained with 75 MBq of FDG and maximum imaging time of 5 minutes. FDG PET studies on whole-body PET scanners for detection of breast cancer are typically performed with a dose at least five times as high and in as long as 1 hour (8). Our PEM instrument system performs reliably in a clinical setting and could potentially be a useful complementary imaging modality to x-ray mammography.
| Acknowledgments |
|---|
| Footnotes |
|---|
Author contributions: Guarantor of integrity of entire study, C.J.T.; study concepts, C.J.T., R.L., A.L., J.H.G.; study design, C.J.T., R.L., A.L.; definition of intellectual content, K.M., C.J.T.; literature research, K.M.; clinical studies, K.M., C.J.T., R.L., A.L., J.H.G.; experimental studies, K.M., M.A., C.J.T., A.M.B., J.L.R.; data acquisition and analysis, K.M., M.A., C.J.T., A.M.B., J.L.R.; manuscript preparation, K.M., M.A.; manuscript editing, K.M., M.A., C.J.T.; manuscript review, K.M., M.A., C.J.T., R.L., A.L.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. L. Rosen, W. B. Eubank, and D. A. Mankoff FDG PET, PET/CT, and Breast Cancer Imaging RadioGraphics, October 1, 2007; 27(suppl_1): S215 - S229. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Murthy, M. Aznar, C. J. Thompson, A. Loutfi, R. Lisbona, and J. H. Gagnon Results of Preliminary Clinical Trials of the Positron Emission Mammography System PEM-I: A Dedicated Breast Imaging System Producing Glucose Metabolic Images Using FDG J. Nucl. Med., November 1, 2000; 41(11): 1851 - 1858. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |